Summary
Danaher Corporation (DHR) filed an 8-K on January 8, 2018, to provide anticipated financial performance updates in advance of their presentation at the J.P. Morgan Healthcare Conference on January 9, 2018. The filing includes a press release and a presentation slide, which contain forward-looking information regarding their expected results for the fourth quarter and full year 2017. Investors should note that this information is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it is not automatically incorporated into future SEC filings unless specifically referenced.
Key Highlights
- 1Danaher provided an update on its anticipated financial performance for Q4 2017 and the full year 2017.
- 2The update was delivered in conjunction with the J.P. Morgan Healthcare Conference.
- 3A press release and a presentation slide detailing the anticipated performance were furnished.
- 4The information is considered forward-looking and relates to preliminary performance expectations.
- 5This 8-K filing serves to inform investors about expected financial results prior to official reporting.
- 6The furnished information is not legally considered "filed" for Section 18 purposes unless explicitly incorporated by reference in a future filing.
Frequently Asked Questions
The primary purpose of this 8-K filing is to provide investors with anticipated financial performance information for Danaher's fourth quarter and full year 2017, ahead of their presentation at the J.P. Morgan Healthcare Conference.
The detailed financial performance information is contained within the furnished press release (Exhibit 99.1) and the selected presentation slide (Exhibit 99.2) attached to this 8-K filing.
No, the information provided in this 8-K is an anticipation of financial performance and is furnished, not officially filed. Official financial results would typically be reported in a subsequent 10-Q or 10-K filing.
No, the filing explicitly states that the furnished information shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference into any other filing unless specifically stated in a future filing. Therefore, it does not alter the treatment of future SEC submissions.